The Upper Esophageal Sphincter Assist Device Is Associated With Symptom Response in Reflux-Associated Laryngeal Symptoms

Rena Yadlapati, Jenna Craft, Christopher J. Adkins, John Erik Pandolfino

Research output: Contribution to journalShort survey

Abstract

Reflux-associated laryngeal symptoms (RALS) is the process in which chronic laryngeal symptoms are related to gastroesophagopharyngeal reflux.1 Impairment of upper esophageal sphincter (UES) reflexes may predispose to esophagopharyngeal reflux.1 The novel noninvasive nonpharmacologic UES assist device (UESAD) applies external cricoid pressure to augment intraluminal UES pressure by 20 to 30 mm Hg and reduce esophagopharyngeal reflux events.2 This study aimed to assess the therapeutic efficacy of the UESAD in a pragmatic clinical setting, and to identify factors associated with symptom response among patients with suspected RALS.

Original languageEnglish (US)
Pages (from-to)1670-1672
Number of pages3
JournalClinical Gastroenterology and Hepatology
Volume16
Issue number10
DOIs
StatePublished - Oct 1 2018

Fingerprint

Upper Esophageal Sphincter
Equipment and Supplies
Pressure
Reflex
Therapeutics

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

@article{1e55a37a3456419899d0614e54cb4d96,
title = "The Upper Esophageal Sphincter Assist Device Is Associated With Symptom Response in Reflux-Associated Laryngeal Symptoms",
abstract = "Reflux-associated laryngeal symptoms (RALS) is the process in which chronic laryngeal symptoms are related to gastroesophagopharyngeal reflux.1 Impairment of upper esophageal sphincter (UES) reflexes may predispose to esophagopharyngeal reflux.1 The novel noninvasive nonpharmacologic UES assist device (UESAD) applies external cricoid pressure to augment intraluminal UES pressure by 20 to 30 mm Hg and reduce esophagopharyngeal reflux events.2 This study aimed to assess the therapeutic efficacy of the UESAD in a pragmatic clinical setting, and to identify factors associated with symptom response among patients with suspected RALS.",
author = "Rena Yadlapati and Jenna Craft and Adkins, {Christopher J.} and Pandolfino, {John Erik}",
year = "2018",
month = "10",
day = "1",
doi = "10.1016/j.cgh.2018.01.031",
language = "English (US)",
volume = "16",
pages = "1670--1672",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "10",

}

The Upper Esophageal Sphincter Assist Device Is Associated With Symptom Response in Reflux-Associated Laryngeal Symptoms. / Yadlapati, Rena; Craft, Jenna; Adkins, Christopher J.; Pandolfino, John Erik.

In: Clinical Gastroenterology and Hepatology, Vol. 16, No. 10, 01.10.2018, p. 1670-1672.

Research output: Contribution to journalShort survey

TY - JOUR

T1 - The Upper Esophageal Sphincter Assist Device Is Associated With Symptom Response in Reflux-Associated Laryngeal Symptoms

AU - Yadlapati, Rena

AU - Craft, Jenna

AU - Adkins, Christopher J.

AU - Pandolfino, John Erik

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Reflux-associated laryngeal symptoms (RALS) is the process in which chronic laryngeal symptoms are related to gastroesophagopharyngeal reflux.1 Impairment of upper esophageal sphincter (UES) reflexes may predispose to esophagopharyngeal reflux.1 The novel noninvasive nonpharmacologic UES assist device (UESAD) applies external cricoid pressure to augment intraluminal UES pressure by 20 to 30 mm Hg and reduce esophagopharyngeal reflux events.2 This study aimed to assess the therapeutic efficacy of the UESAD in a pragmatic clinical setting, and to identify factors associated with symptom response among patients with suspected RALS.

AB - Reflux-associated laryngeal symptoms (RALS) is the process in which chronic laryngeal symptoms are related to gastroesophagopharyngeal reflux.1 Impairment of upper esophageal sphincter (UES) reflexes may predispose to esophagopharyngeal reflux.1 The novel noninvasive nonpharmacologic UES assist device (UESAD) applies external cricoid pressure to augment intraluminal UES pressure by 20 to 30 mm Hg and reduce esophagopharyngeal reflux events.2 This study aimed to assess the therapeutic efficacy of the UESAD in a pragmatic clinical setting, and to identify factors associated with symptom response among patients with suspected RALS.

UR - http://www.scopus.com/inward/record.url?scp=85046752338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046752338&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2018.01.031

DO - 10.1016/j.cgh.2018.01.031

M3 - Short survey

VL - 16

SP - 1670

EP - 1672

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 10

ER -